Inferra AIResearch Tools

Inferra AI / Company / RVTY

Revvity

RVTY · Health Care

Last earnings Aug 4, 2026  ·  Next earnings Nov 3, 2026

Key results

EPSquarter

$0.46

The Company reported GAAP earnings per share of $0.46, as compared to $0.45 in the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Revenuequarter

$720 million

Revenue for the quarter was $720 million, as compared to $692 million in the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

GAAP operating incomequarter

$91 million

GAAP operating income from continuing operations for the quarter was $91 million, as compared to $86 million for the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

GAAP operating profit margin from continuing operations was 12.6% as a percentage of revenue, as compared to 12.4% in the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Adjusted earnings per share from continuing operations for the quarter was $1.18, as compared to $1.22 in the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Adjusted operating incomequarter

$192 million

Adjusted operating income was $192 million, as compared to $199 million for the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Adjusted operating profit margin was 26.6% as a percentage of revenue, as compared to 28.8% in the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Financial Overview by Reporting Segment Life Sciences Second quarter 2025 revenue was $366 million, as compared to $349 million in the same period a year ago.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Selling, general, and administrativequarter

$248,526 thousand

Selling, general and administrative expenses 248,526 251,650 498,245 512,221

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Research and developmentquarter

$53,270 thousand

Research and development expenses 53,270 48,132 106,867 98,492

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Net incomequarter

$53,948 thousand

Net income $ 53,948 $ 55,360 $ 96,185 $ 81,373

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

AI analysis

Q2 2025 · reported Jul 28, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Revenue · Q2 2025
$720M
+4.0% +$28M vs year ago computed from stated figures
EX-99 · Jul 28, 2025
EPS · Q2 2025
$0.46
+2.2% vs year ago computed from stated figures
EX-99 · Jul 28, 2025
Net income · Q2 2025
$53,948 thousand
EX-99 · Jul 28, 2025
GAAP operating income · Q2 2025
$91M
+5.8% +$5M vs year ago computed from stated figures
EX-99 · Jul 28, 2025

The quarter in charts

Revenue — quarterly

As stated

0267533800$692MSame quarter last year$720MQ2 2025

EX-99 · Jul 28, 2025 Statement values as stated in the release.

Diluted EPS — GAAP

Per diluted share, as stated

00.170.330.5$0.45Same quarter last year$0.46Q2 2025 (quarter)

EX-99 · Jul 28, 2025 EPS values as stated in the release.

Guidance ladder — revenue

Delivered vs the company's guided range

EX-99 · Jul 28, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.

Headline figures

MetricQ2 2025Prior qtrYear ago
EPS$0.46—$0.45
Revenue$720 million—$692 million
GAAP operating income$91 million—$86 million
Adjusted operating income$192 million—$199 million
Selling, general, and administrative$248,526 thousand——
Research and development$53,270 thousand——
Net income$53,948 thousand——

EX-99 · Jul 28, 2025

Guidance · company-stated

Direction: Raised

Revenue$2.88 billion

“Full Year 2025 Guidance For the full year 2025, the Company is raising its full year revenue guidance to $2.84-$2.88 billion to reflect recent changes in foreign currency exchange rates and assumes 2% to 4% organic growth.”

Company outlook — Lowered

“These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management s ability to make useful forecasts.”

Midpoint vs latest-quarter revenue+300.0%computed from stated figures

Classified from the release's primary full-year outlook statement.

Next earningsNov 3, 2026Verified from the company’s own announcement

Capital allocation

We use the term adjusted net interest and other expense to refer to GAAP net interest and other expense, excluding adjustments for mark-to-market accounting on post-retirement benefits, changes in foreign exchange and interest associated with acquisitions and divestitures, changes in the value of investments and debt extinguishment costs.

We use the term free cash flow to refer to net cash provided by (used in) operating activities of continuing operations, less payments for additions to property, plant and equipment from continuing operations ( capital expenditures ) plus the proceeds from sales of plant, property and equipment from continuing operations ( capital disposals ).

What changed vs last quarter

  • Guide midpoint vs latest-quarter revenue +300.0% computed from stated figures
General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

The Company reported GAAP earnings per share of $0.46, as compared to $0.45 in the same period a year ago

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

Direction: Raised

Revenue: “Full Year 2025 Guidance For the full year 2025, the Company is raising its full year revenue guidance to $2.84-$2.88 billion to reflect recent changes in foreign currency exchange rates and assumes 2% to 4% organic growth.”

Revenue — Raised (“raising”)
“Full Year 2025 Guidance For the full year 2025, the Company is raising its full year revenue guidance to $2.84-$2.88 billion to reflect recent changes in foreign currency exchange rates and assumes 2% to 4% organic growth.”

Company outlook — Lowered (“reduce”)
“These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management s ability to make useful forecasts.”

Classified from the release's primary full-year outlook statement.

Capital allocation

We use the term adjusted net interest and other expense to refer to GAAP net interest and other expense, excluding adjustments for mark-to-market accounting on post-retirement benefits, changes in foreign exchange and interest associated with acquisitions and divestitures, changes in the value of investments and debt extinguishment costs.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

We use the term free cash flow to refer to net cash provided by (used in) operating activities of continuing operations, less payments for additions to property, plant and equipment from continuing operations ( capital expenditures ) plus the proceeds from sales of plant, property and equipment from continuing operations ( capital disposals ).

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

We use the term adjusted net income to refer to GAAP income from continuing operations, excluding amortization of intangible assets, debt extinguishment costs, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and settlements, significant environmental charges, changes in the value of investments, disposition of businesses and assets, net, changes in foreign exchange and interest associated with acquisitions and divestitures, asset impairments and restructuring and other charges.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

We use the term adjusted earnings per share from continuing operations, adjusted earnings per share, adjusted EPS, or adjusted EPS from continuing operations to refer to GAAP earnings per share from continuing operations, excluding amortization of intangible assets, debt extinguishment costs, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and settlements, significant environmental charges, changes in the value of investments, disposition of businesses and assets, net, changes in foreign exchange and interest associated with acquisitions and divestitures, asset impairments and restructuring and other charges.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Debt extinguishment costs we incur costs and income related to the extinguishment of debt including make-whole payments to debt holders, accelerated amortization of debt fees and discounts, and expense or income from hedges to lock in make-whole payments.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Management s Discussion and Analysis of Financial Condition and Results of Operations 25 Overview 25 Critical Accounting Policies and Estimates 25 Consolidated Results of Continuing Operations 26 Reporting Segment Results of Continuing Operations 28 Liquidity and Capital Resources 29 Dividends 31 Effects of Recently Adopted and Issued Accounting Pronouncements 31 Item 3.

SEC original ↗Revvity — 10-Q Quarterly report10-QAug 11, 2026

Strategy & priorities

Note 12: Derivatives and Hedging Activities The Company uses derivative instruments as part of its risk management strategy only, and includes derivatives utilized as economic hedges that are not designated as hedging instruments.

SEC original ↗Revvity — 10-Q Quarterly report10-QAug 11, 2026

Risks & headwinds

We use the term adjusted SG A expense to refer to GAAP SG A expense, excluding amortization of intangible assets, purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and settlements, asset impairments, significant environmental charges, and restructuring and other charges.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

We use the term adjusted operating income to refer to GAAP operating income, excluding amortization of intangible assets, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and settlements, significant environmental charges, asset impairments, and restructuring and other charges.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

We use the term adjusted net income to refer to GAAP income from continuing operations, excluding amortization of intangible assets, debt extinguishment costs, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and settlements, significant environmental charges, changes in the value of investments, disposition of businesses and assets, net, changes in foreign exchange and interest associated with acquisitions and divestitures, asset impairments and restructuring and other charges.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

We use the term adjusted earnings per share from continuing operations, adjusted earnings per share, adjusted EPS, or adjusted EPS from continuing operations to refer to GAAP earnings per share from continuing operations, excluding amortization of intangible assets, debt extinguishment costs, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and settlements, significant environmental charges, changes in the value of investments, disposition of businesses and assets, net, changes in foreign exchange and interest associated with acquisitions and divestitures, asset impairments and restructuring and other charges.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Significant litigation matters and settlements we incur expenses related to significant litigation matters, including the costs to settle or resolve various claims and legal proceedings.

SEC original ↗Revvity — Earnings release (8-K exhibit)EX-99Jul 28, 2025

Legal Proceedings 33 Item 1A.

SEC original ↗Revvity — 10-Q Quarterly report10-QAug 11, 2026

Documents

Earnings deck slides

0 decks with slide view

Revvity — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Revvity — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Gilead Sciences (GILD) Health CareGenmab (GMAB) Health CareAlcon (ALC) Health CareArgenx (ARGX) Health CareSanofi (SNY) Health CareMerck & Co. (MRK) Health CareXencor Inc (XNCR) Health CareIllumina, Inc. (ILMN) Health Care

Filings

31 documents

Earnings releases

14 documents

Presentations

2 documents

Transcripts

0 documents

No transcripts for Revvity are held in this edition of the library.

Mentioned by

1 company

Other tracked companies whose held documents mention Revvity by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.